SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-070762
Filing Date
2024-08-19
Accepted
2024-08-19 17:01:50
Documents
89
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0210837-10q_avalon.htm   iXBRL 10-Q 1583589
2 CERTIFICATION ea021083701ex31-1_avalon.htm EX-31.1 11632
3 CERTIFICATION ea021083701ex31-2_avalon.htm EX-31.2 11987
4 CERTIFICATION ea021083701ex32-1_avalon.htm EX-32.1 3927
5 CERTIFICATION ea021083701ex32-2_avalon.htm EX-32.2 3618
  Complete submission text file 0001213900-24-070762.txt   8933674

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE avco-20240630.xsd EX-101.SCH 85229
7 XBRL CALCULATION FILE avco-20240630_cal.xml EX-101.CAL 49477
8 XBRL DEFINITION FILE avco-20240630_def.xml EX-101.DEF 439682
9 XBRL LABEL FILE avco-20240630_lab.xml EX-101.LAB 730871
10 XBRL PRESENTATION FILE avco-20240630_pre.xml EX-101.PRE 433191
92 EXTRACTED XBRL INSTANCE DOCUMENT ea0210837-10q_avalon_htm.xml XML 1029070
Mailing Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728
Business Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728 732-780-4400
Avalon GloboCare Corp. (Filer) CIK: 0001630212 (see all company filings)

IRS No.: 471685128 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38728 | Film No.: 241221438
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)